Home / Pharmaceuticals / In-Vitro Fertilization Market By Instrument (Disposable Devices, Culture Media and Capital Equipment), By Type (Fresh Donor, Frozen Donor, Fresh Non-Donor and Frozen Non-Donor), By End User (Fertility Clinics and Hospitals) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

In-Vitro Fertilization Market By Instrument (Disposable Devices, Culture Media and Capital Equipment), By Type (Fresh Donor, Frozen Donor, Fresh Non-Donor and Frozen Non-Donor), By End User (Fertility Clinics and Hospitals) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Apr 2019 | Report Code: 59678-04-19

Industry Outlook

The in-vitro fertilization market is set to reach from US$ 15,604.7 Mn in 2017 to US$ 36,854.0 Mn in 2026 projecting outstanding growth at a compounded annual growth rate of 10.1% during the forecast period from 2018 to 2026. Significant rise in couples to have children at later stage of life owing to increasing preference for professional career and technological adoption in IVF treatment will drive the market growth in the forthcoming years.

Market Synopsis

In-Vitro Fertilization Market

Get a sample copy for more information

"Increased research activites to improve culture media and capability in sperm preservation without losing on quality drive the market growth for culture media"

Culture media are currently holding the largest market share by instruments in the in-vitro fertilization market. Chief attributing factors are increased research activites in improving culture media and capability in preserving sperm without losing on quality. Increasing demand for egg processing media and establishment of numerous egg cryobanks further bolster the market growth for culture media. Strict regulatory mandates and need for maintaining optimum sterile conditions will propel the market growth of disposable devices at a faster rate.

In-Vitro Fertilization Market

Get a sample copy for more information

"Frozen non-donor will be the fastest growing segment due to excellent live birth rate, better implementation and lower miscarriage rate"

Fresh non-donor is currently reigning the type segment for in-vitro fertilization market. High success rate in the first attempt is the major factor responsible for its impressive market growth. Frozen non-donor will be showcasing outstanding growth in the next few years on account of excellent live birth rate, better implementation, reduced cases of ectopic pregnancy and lower miscarriage rate.

In-Vitro Fertilization Market

Get a sample copy for more information

"Availability of sophisticated equipment and significant rise in couples opting Assistive Reproductive Technology (ART) drive the market growth for fertility clinics"

Fertility clinics are dominating the end user segment for in-vitro fertilization market. Significant rise in the couples opting for ART treatment, Intracytoplasmic Sperm Injection (ICST) and Gamete Intrafallopian Transfer (GIFT) drive the fertility clinics market growth. Hospitals are showcasing steady growth on account of enhanced government funding to provide IVF treatment to poor families and rising public health awareness pertaining to infertility treatment.

In-Vitro Fertilization Market

"Rising prevalence of infertility and adoption of sophisticated technology pertaining to IVF drives the market growth in North America region"

North America is accountable for 35% market growth and is the leading regional segment for in-vitro fertilization market. The assisting factors responsible for its market dominance are rising prevalence of infertility. As per the research findings of American Society for Reproductive Medicine (ASRM), approximately 6.7 million women are suffering with infertility in the United States, which represents 11.0% of the reproductive population. Europe holds 30% market share owing to the government initiatives of providing monetary benefits pertaining to gametes freezing and IVF cycles. Asia Pacific represents 20% market share and will capture the market in the next few years on account of presence of large target population, adoption of sophisticated technology and low treatment cost in comparison to developed countries.

In-Vitro Fertilization Market

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

In-vitro fertilization market segmentation is as follows:

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Instrument (2016–2026; US$ Mn)
 • Disposable Devices
 • Culture Media
 • Capital Equipment

 By Type (2016–2026; US$ Mn)
 • Fresh Donor
 • Frozen Donor
 • Fresh Non-Donor
 • Frozen Non-Donor

 By End User (2016–2026; US$ Mn)
 • Fertility Clinics
 • Hospitals

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Biopharmaceuticals specializing in in-vitro fertilization market are Boston IVF, Cook Medical, Inc., Cooper Surgical, Inc., EMD Serono, Inc., Genea Biomedx, Irvine Scientific, Inc., OvaScience, Inc., Progyny, Inc., Thermo Fisher Scientific, Inc. and Vitrolife AB.

Key questions answered in this report

  • Which major players are providing culture media and disposable devices related to in-vitro fertilization treatment?
  • What are the latest treatment protocols adopted in in-vitro fertilization?
  • Which factors are responsible for rising prevalence of infertility throughout the world?
  • What will be the market size for disposable devices in the near future?
  • Why is fresh non-donor the leading type segment in in-vitro fertilization market?
  • What will be the market performance of fertility clinics and hospitals during the forecast period?
  • What is the treatment regimen adopted in developed regions such as Europe and North America?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global IVF Market Portraiture
2.2. Global IVF Market, by Instrument, 2017 (US$ Mn)
2.3. Global IVF Market, by Type, 2017 (US$ Mn)
2.4. Global IVF Market, by End User, 2017 (US$ Mn)
2.5. Global IVF Market, by Geography, 2017 (US$ Mn)

Chapter 3. In-Vitro Fertilization (IVF) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global IVF Market, by Key Players, 2017

Chapter 4. Global In-Vitro Fertilization (IVF) Market, by Instrument
4.1. Overview
4.2. Disposable Devices
4.3. Culture Media
4.4. Capital Equipment

Chapter 5. Global In-Vitro Fertilization (IVF) Market, by Type
5.1. Overview
5.2. Fresh Donor
5.3. Frozen Donor
5.4. Fresh Non-Donor
5.5. Frozen Non-Donor

Chapter 6. Global In-Vitro Fertilization (IVF) Market, by End User
6.1. Overview
6.2. Fertility Clinics
6.3. Hospitals

Chapter 7. Global In-Vitro Fertilization (IVF) Market, by Geography
7.1. Overview
7.2. North America IVF Market Analysis, 2016 – 2026
7.2.1. North America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.2.2. North America IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.2.3. North America IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.2.4. North America IVF Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe IVF Market Analysis, 2016 – 2026
7.3.1. Europe IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.3.2. Europe IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.3.4. Europe IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific IVF Market Analysis, 2016 – 2026
7.4.1. Asia Pacific IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America IVF Market Analysis, 2016 – 2026
7.5.1. Latin America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.5.2. Latin America IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.5.4. Latin America IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa IVF Market Analysis, 2016 – 2026
7.6.1. MEA IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.6.2. MEA IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.6.3. MEA IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.6.4. MEA IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Boston IVF
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Cook Medical, Inc.
8.3. Cooper Surgical, Inc.
8.4. EMD Serono, Inc.
8.5. Genea Biomedx
8.6. Irvine Scientific, Inc.
8.7. OvaScience, Inc.
8.8. Progyny, Inc.
8.9. Thermo Fisher Scientific, Inc.
8.10. Vitrolife AB

* IVF - In-Vitro Fertilization

FIG. 1 In-Vitro Fertilization (IVF) Market: Research Methodology
FIG. 2 IVF: Market Segmentation
FIG. 3 Global IVF Market, by Instrument, 2017 (US$ Mn)
FIG. 4 Global IVF Market, by Type, 2017 (US$ Mn)
FIG. 5 Global IVF Market, by End User, 2017 (US$ Mn)
FIG. 6 Global IVF Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: by Geography, 2017
FIG. 8 Competitive Analysis: Global IVF Market, by Key Players, 2017
FIG. 9 Global Disposable Devices Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 10 Global Culture Media Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 11 Global Capital Equipment Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 12 Global Fresh Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 13 Global Frozen Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 14 Global Fresh Non-Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 15 Global Frozen Non-Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 16 Global Fertility Clinics Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 17 Global Hospitals Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 18 U.S. IVF Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada IVF Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. IVF Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany IVF Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe IVF Market, 2016 – 2026 (US$ Mn)
FIG. 23 China IVF Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan IVF Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific IVF Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil IVF Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico IVF Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America IVF Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC IVF Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of MEA IVF Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global In-Vitro Fertilization (IVF) Market Portraiture
TABLE 2 Global IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 3 Global IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global IVF Market , by End User, 2016 – 2026 (US$ Mn)
TABLE 5 Global IVF Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 7 North America IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 9 North America IVF Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 11 Europe IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 13 Europe IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 26 Boston IVF: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Cooper Surgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Genea Biomedx: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Irvine Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 OvaScience, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Progyny, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Vitrolife AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients